Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2022-08-05 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
德勤华永会计师事务所(特殊普通合伙)关于康泰医学系统（秦皇岛）股份有限公司以募集资金置换自筹资金预先投入募投项目和已支付发行费用的专项审核报告
Audit Report / Information Classification · 95% confidence The document is an audit report issued by Deloitte Hua Yong CPA firm regarding the use of raised funds by 康泰医学系统（秦皇岛）股份有限公司 as of July 29, 2022. It includes the auditor's responsibilities, the board's responsibilities, and the auditor's opinion on the special explanation of the use of funds raised to replace self-raised funds pre-invested in projects and paid issuance expenses. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and it is titled as an "审核报告" (Audit Report). The document length is 3489 characters, which is relatively short but contains substantive audit opinion and details, not just an announcement or certification. It is not a full annual or interim report, nor a simple announcement or certification letter. Therefore, it fits the category of an Audit Report / Information (AR). Q3 2022
2022-08-05 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转债并在创业板上市之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" (Securities Listing Sponsorship Letter) issued by 中信建投证券股份有限公司 regarding 康泰医学系统（秦皇岛）股份有限公司's issuance of convertible bonds and listing on the ChiNext board. It contains detailed company background, business overview, financial data for multiple years including balance sheets, income statements, cash flow statements, risk disclosures, and regulatory compliance statements. The document is comprehensive and exceeds 15,000 characters, indicating it is a full report rather than a brief announcement. The content focuses on the securities issuance and listing sponsorship, which is a specialized regulatory filing related to capital markets and securities issuance. This type of document is not an annual report, earnings release, or management discussion but a formal sponsorship document required for the issuance and listing process in China. According to the filing definitions, this fits best under Capital/Financing Update (CAP) as it relates to updates on company fundraising and capital structure changes through convertible bond issuance and listing. Therefore, the appropriate classification is CAP with high confidence.
2022-07-15 Chinese
康泰医学系统（秦皇岛）股份有限公司创业板向不特定对象发行可转换公司债券上市公告书
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the issuance and listing of convertible corporate bonds by 康泰医学系统（秦皇岛）股份有限公司. It includes extensive information about the bond issuance, underwriting, bond terms, credit rating, issuance scale, bondholder details, and regulatory approvals. The document is titled as a "上市公告书" which translates to "Listing Announcement" or "Offering Circular" for the convertible bonds. It is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a comprehensive capital market document related to a financing activity, specifically the issuance and listing of convertible bonds. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-07-15 Chinese
北京市长安律师事务所关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券在深圳证券交易所上市的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the issuance and listing of convertible corporate bonds by 康泰医学系统（秦皇岛）股份有限公司 on the Shenzhen Stock Exchange. It contains detailed legal analysis, compliance checks with relevant laws and regulations, approvals from company bodies, and confirmations of the company's qualifications and conditions for the bond issuance. The document is not a financial report, audit report, or earnings release, nor is it a brief announcement or a proxy solicitation. It is a standalone legal opinion related to a capital market transaction, specifically the issuance of convertible bonds. This fits best under the category of Capital/Financing Update (CAP), as it pertains to the company's fundraising and financing activities through bond issuance.
2022-07-15 Chinese
关于签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a convertible bond issuance by 康泰医学系统（秦皇岛）股份有限公司. It details the amount raised, the establishment of special accounts for the funds, and the terms of the supervision agreement among the company, banks, and the securities firm. There are no financial statements or detailed financial performance data presented. The document is relatively short (2661 characters) and serves as a formal announcement about the fundraising and regulatory compliance related to the capital raised. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or audit report.
2022-07-13 Chinese
康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券发行结果公告
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the issuance results of convertible bonds by 康泰医学系统（秦皇岛）股份有限公司. It details the subscription amounts, underwriting, and allocation results of the convertible bonds. There is no financial statement or comprehensive financial report included, but rather a formal disclosure of the issuance outcome. This fits the category of Capital/Financing Update, which covers updates on company fundraising and financing activities.
2022-07-06 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.